| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 5006 | 2018 |
| Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy Y Min, KC Roche, S Tian, MJ Eblan, KP McKinnon, JM Caster, S Chai, ... Nature nanotechnology 12 (9), 877-882, 2017 | 654 | 2017 |
| Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1–dependent mechanism that is up-regulated by interleukin-13 SL Highfill, PC Rodriguez, Q Zhou, CA Goetz, BH Koehn, R Veenstra, ... Blood, The Journal of the American Society of Hematology 116 (25), 5738-5747, 2010 | 530 | 2010 |
| L-Selectinhi but not the L-selectinlo CD4+ 25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection PA Taylor, A Panoskaltsis-Mortari, JM Swedin, PJ Lucas, RE Gress, ... Blood 104 (12), 3804-3812, 2004 | 434 | 2004 |
| Leukocyte migration and graft-versus-host disease CA Wysocki, A Panoskaltsis-Mortari, BR Blazar, JS Serody Blood 105 (11), 4191-4199, 2005 | 424 | 2005 |
| B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer DP Hollern, N Xu, A Thennavan, C Glodowski, S Garcia-Recio, KR Mott, ... Cell 179 (5), 1191-1206. e21, 2019 | 392 | 2019 |
| In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations MJ Carlson, ML West, JM Coghill, A Panoskaltsis-Mortari, BR Blazar, ... Blood, The Journal of the American Society of Hematology 113 (6), 1365-1374, 2009 | 385 | 2009 |
| Anti-CD30 CAR-T cell therapy in relapsed and refractory Hodgkin lymphoma CA Ramos, NS Grover, AW Beaven, PD Lulla, MF Wu, A Ivanova, T Wang, ... Journal of clinical oncology 38 (32), 3794-3804, 2020 | 357 | 2020 |
| Intravascular catheter exchange and duration of candidemia JH Rex, JE Bennett, AM Sugar, PG Pappas, J Serody, JE Edwards, ... Clinical infectious diseases 21 (4), 994-996, 1995 | 356 | 1995 |
| Genomic analysis of immune cell infiltrates across 11 tumor types MD Iglesia, JS Parker, KA Hoadley, JS Serody, CM Perou, BG Vincent Journal of the National Cancer Institute 108 (11), djw144, 2016 | 343 | 2016 |
| Alternative tumour-specific antigens CC Smith, SR Selitsky, S Chai, PM Armistead, BG Vincent, JS Serody Nature Reviews Cancer 19 (8), 465-478, 2019 | 330 | 2019 |
| Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease CA Wysocki, QI Jiang, A Panoskaltsis-Mortari, PA Taylor, KP McKinnon, ... Blood 106 (9), 3300-3307, 2005 | 326 | 2005 |
| Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib K Sun, LA Welniak, A Panoskaltsis-Mortari, MJ O'Shaughnessy, H Liu, ... Proceedings of the National Academy of Sciences 101 (21), 8120-8125, 2004 | 318 | 2004 |
| Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers OMT Pearce, RM Delaine-Smith, E Maniati, S Nichols, J Wang, S Böhm, ... Cancer discovery 8 (3), 304-319, 2018 | 310 | 2018 |
| Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer MD Iglesia, BG Vincent, JS Parker, KA Hoadley, LA Carey, CM Perou, ... Clinical Cancer Research 20 (14), 3818-3829, 2014 | 303 | 2014 |
| Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma CC Smith, KE Beckermann, DS Bortone, AA De Cubas, LM Bixby, SJ Lee, ... The Journal of clinical investigation 128 (11), 4804-4820, 2019 | 269 | 2019 |
| CSF-1–dependant donor-derived macrophages mediate chronic graft-versus-host disease KA Alexander, R Flynn, KE Lineburg, RD Kuns, BE Teal, SD Olver, M Lor, ... The Journal of clinical investigation 124 (10), 4266-4280, 2014 | 245 | 2014 |
| Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans R Flynn, J Du, RG Veenstra, DK Reichenbach, A Panoskaltsis-Mortari, ... Blood, The Journal of the American Society of Hematology 123 (25), 3988-3998, 2014 | 237 | 2014 |
| Ibrutinib treatment ameliorates murine chronic graft-versus-host disease JA Dubovsky, R Flynn, J Du, BK Harrington, Y Zhong, B Kaffenberger, ... The Journal of clinical investigation 124 (11), 4867-4876, 2014 | 225 | 2014 |
| Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new JM Coghill, S Sarantopoulos, TP Moran, WJ Murphy, BR Blazar, ... Blood, The Journal of the American Society of Hematology 117 (12), 3268-3276, 2011 | 224 | 2011 |